MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway

Published: 13 November 2025| Version 2 | DOI: 10.17632/yyt6c95gcf.2
Contributor:
HENGYU REN

Description

Data of the article :MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway

Files

Categories

Breast Cancer, Cholesterol Metabolism

Licence